Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

2017 Speakers

Sally Chung

Sally Chung

Project Director, GSK

Read more

Sally Chung is currently a Project Director working in global medicine development for amyloidosis at GSK R&D. A dynamic and strategic thinking leader with almost 20 years of pharmaceutical industry experience, Sally has a deep expertise in leading medicine development project teams, clinical development, clinical operations, formulation development, alliance management, medical affairs and regulatory. A well established matrix leader with excellent organizational and communication skills to drive high performance.

Sheila Khawaja

Sheila Khawaja

Board Member, EU Division, WAPO

Read more

Sheila Khawaja is a Board Member of the World Alliance of Pituitary Organizations (WAPO) an acromegaly patient since 2003. WAPO is a non-profit entity that unites the global international pituitary community and aims optimizing treatment and care of all patients with pituitary and related conditions. Sheila is responsible for EU Relations and fundraising opportunities that will enable WAPO to carry forward the Action Plan set forth by the Board. Since 2013 she leads her own affiliated local Patient Organization, Associazione Nazionale Italiana Patologie Ipofisarie – Friuli-Venezia-Giulia (ANIPI-FVG) based in Trieste, Italy. Public awareness through workshops, walk-a-thons and the financial endorsement of medical research are constantly evolving in the organization and high on the agenda; since 2014 Sheila is also on the national board of ANIPI-Italia acting as a national representative when the national organization participates in international events.

Sheila is bilingual in English and Italian and obtained her Master’s degree in Translation and Interpretation at the University of Trieste in 2012. In 2016 she joined the RareConnect translation group of EURORDIS to ensure that the Italian online community has easy access to important information on rare diseases. She plans to have a more active role in the coming months.

Last but not least, Sheila was selected as one of the 40 students for the 2017 EURORDIS Summer school.

Terttu Haring

Terttu Haring

VP Global Head of Trial Operations, Sanofi

Read more

Based in Gouda – office in Chilly Mazarin

Business Experience

Physician with specialization in Pharmaceutical Medicine
Practiced medicine in NL hospitals for 3 years in General surgery and OB/GYN.
1997: Joined pharmaceutical clinical development as Principal Investigator in Clinical Pharmacology: phase 1 and 2a. Developed in Kendle International to global Therapeutic Director for Women’s Health.
2003: Joined Sanofi Netherlands as local Director for Clinical Research Unit. Lead department through Aventis integration, built strong collaborations with Belgium and UK teams, active contributor and leader in Dutch Clinical Trial Foundation (influencing legislation, collaboration and education on clinical trials between academia, hospitals, government and industry)
2009: Became one of the first Region Heads in CSU network, building 3 clusters and Region, in new regional structure.
2011: Integration of Genzyme (European) clinical operations activities into CSO.
2014: started as global head of Trial Operations Department

Education and Training

1994: Medical Degree, Maastricht University, The Netherlands
2001: registration as Pharmaceutical Physician, NVFG, Netherlands
Fluent speaking/writing: Dutch, English
1984: exchange student, senior year Ithaca HighSchool, Ithaca, NY, USA
2002/2003: expatriation to UK (for Kendle), European HC

Arndt Schmitz

Arndt Schmitz

Head of Research Biobank, Clinical Sciences Operations, Bayer

Read more

Dr Arndt A. Schmitz has 15 years of experience at Bayer’s Pharmaceuticals division. For the last years, he is working at Clinical Sciences supporting early clinical trials, spear-heading the Research Biobank by collaborating with academic clinicians internationally. His focus recently switched towards novel uses of the digital annotation of the biospecimens. Prior joining pharma, he was a post-doc at Cold Spring Harbor Laboratory in the USA, based on his PhD in biochemistry at Biocenter Basel, Switzerland, and his diploma in chemistry. Prior, after finishing high school, he had worked as an assistant nurse at his home town’s local hospital.

Trishna Bharadia

Trishna Bharadia

Multiple Sclerosis/Chronic Illness Advocate and Expert Patient

Read more

Trishna Bharadia is a multi-award winning advocate for people with multiple sclerosis and chronic illness. Diagnosed with MS in 2008, aged 28, she's used her experiences to raise awareness and improve support for people affected by MS and other chronic illnesses. A full time Spanish-English translator, in her spare time she collaborates with organisations in the UK and abroad, including charities, non-profits and pharmaceutical companies to help improve patient experience and engagement. She’s a writer, blogger, vlogger and inspirational/expert patient speaker, as well as advising on projects, research proposals and diversity strategies, and is regular contributor in the media for MS-related issues. She’s a patron/ambassador for several charities and is currently a member of “The Ozone” virtual round table for key opinion leaders across healthcare specialities.

TWITTER: @TrishnaBharadia

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription


Speaker_Name

Pinal Patel

Strategic Recruitment Lead, BMS

Read more

Pinal Patel is a Strategic Recruitment Lead within Global Clinical Operations at Bristol-Myers Squibb. Prior to joining Bristol-Myers Squibb, she was a Study Coordinator at Yale University, School of Medicine Psychiatry working on implementing clinical trials for the Neuroscience portfolio. Pinal graduated from Connecticut College with a BS degree in Psychology. In her current role, her focus is on building novel, fit for purpose patient and site centric strategies to drive enrollment for clinical trials in Oncology space. Understanding the patient journey is at the center of it all in identifying risks and opportunities to achieve the end result. With this insight in mind, Pinal is responsible for building recruitment strategies at portfolio level focused on engaging patients, sites and advocacy groups.

Rémi Chossinand

Rémi Chossinand

Head Clinical Digital Strategy, Sanofi R&D ITS

Read more

Rémi leads Clinical Digital effort in Sanofi towards incorporation of Digital approaches and technologies into Clinical Trial design and executions. Main drivers for this collective effort are operational efficiency, value for patients and better demonstration of therapeutic solution outcomes.

Rémi joined Sanofi ITS Clinical and Regulatory organization in 2016. He was previously Principal with Capgemini Consulting, involved across industry on large Business-IT transformation programs and on digital projects. He holds a MSc in Aeronautical and Space engineering from Supaero University, France.

Bert Hartog

Bert Hartog

Director, R&D Operations Innovation, Janssen

Read more

Bert is currently Innovation Leader at Janssen Pharmaceutica, where he leads transformational innovation projects that have the goal to shape the future of clinical trial execution at Janssen and position Janssen as a role model in patient-centered clinical research.

Bert is a professional in the pharmaceutical industry, with 20+ years’ experience in Clinical Operations, QA, IT and Project Management. He received his MSc in Biomedicine and PhD in Medicine from Utrecht University in the 1990’s, and started his career as CRA with Eli Lilly in the Netherlands. In summer 2015 he joined the Janssen R&D Operations Innovation team. The main focus in his current role is to find ways to facilitate access to trials for patients, to operationalize patient engagement in clinical trials, and to introduce mobile technologies (mHealth) in clinical trials.

Birgit Bauer

Birgit Bauer

Journalist – Epatient – Blogger – Patient Speaker – Social media Expert, Manufaktur für Antworten UG

Read more

Birgit Bauer, E-Patient, Social Media Expert, Journalist, Speaker, EUPATI Fellow 2015.

Manufaktur für Antworten UG, Germany.

Birgit is an E-Patient from Germany. She was diagnosed with Multiple Sclerosis in 2005.

She works with her Business Partner in her own company, the Manufaktur für Antworten UG (www.manufaktur-fuer-antworten.de), which was founded by her in 2005. Birgit works as Social Media and Communication Expert, Journalist and Speaker with a more than 12 years’ experience and a specialisation in Healthcare. She develops Workshops and Talks about the use of Social Media for Target Groups like Patients, Patient Organisation and Industry.

As Consultant she designs Social Media – and Communication Strategies for different Businesses or Patient Projects and brings the Ideas and Strategies into the reality, supervise the different accounts, coach the teams and help to design sustainable networks. She also designs and performs Feasibility Studies for different Clients and creates Influencer Mappings in the Patients Area with a Kooperation Partner.

Birgit Bauer aka @Birgitpower is also one of the most influential Blogger about Multiple Sclerosis and Healthcare in Germany. She started her Blog “Fast normal! Mein Leben mit MS” – “Almost normal – My Life with MS” http://leben-arbeiten-mit-multiple-sklerose.blogspot.de/ in 2007. She supports “emsp” voluntary as “Advisor on Patient Issues” and is involved in different Advisory Boards, Committees and Focus Groups, is Advisor of Patient Issues at the European Multiple Sclerosis Platform and a EUPATI Fellow 2015.

Birgit about Social Media: “Social Media is about people, is about human stories, about sharing with others and understanding real life experiences.”

Derek Stewart

Derek Stewart

Associate Director for Patient & Public Involvement, NIHR

Read more

More information coming soon...

Sue Pavitt

Sue Pavitt

Professor Translational & Applied Health Research, University of Leeds

Read more

Sue Pavitt – Professor in Translational & Applied Health Research, School of Dentistry, University of Leeds. Her PhD was in Human Cancer Genetics and she had a high profile career working with Prof Sir Walter Bodmer mapping the first colorectal cancer gene. She worked on the Human Genome Project at UCL, Oxford and UCSF, USA. In 1998 she was appointed as the Founding Director of TayRen – the premier Scottish multidisciplinary Primary Care Research network and the academic focus of her career changed to an applied health research methodologist specializing in clinical trials and translational research. She is a Board Member of the MRC-NIHR Efficacy & Mechanistic Evaluation programme. Sue is currently Division Head for Applied Health and Clinical Translation and Director of the Dental Translation and Clinical Research Unit, part of the NIHR Leeds Clinical Research Facility. She has a strong innovative portfolio of clinical trials spanning several disease areas. The portfolio is characterized by forging effective, multi-disciplinary research partnerships between clinicians, academics, industry and patients. She is renowned for developing methodological sound projects that are patient-centric with research questions tailored to clinical priorities to maximize NHS impact and patient benefit.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription


Agbor Ndip Ako

Agbor Ndip Ako

Director Clinical Research, GSK

Read more

Agbor joined GSK in September 2016 as a Clinical Research Director in the Africa NCD Open Lab within Global Health R&D and is based in Stevenage. He is also the clinical and medical governance leads for his group that supports collaborative NCD research proposal between GSK and African research institutions. Prior to this he was a Consultant Physician in Diabetes, Endocrinology and general internal medicine at Warrington Hospital and Senior Clinical Lecturer at the University of Manchester; he currently holds honorary contracts with both institutions. Agbor has both clinical and research expertise having completed and/or supervised research on RANKL/RANK/OPG signalling in diabetic vascular calcification, and has won numerous international awards such as the 2009 American Diabetes Association Marc Lavin Award for diabetic foot disease and the 2011 EASD rising star award (European association for the study of Diabetes) for his contribution to research. He has experience in providing scientific and clinical insights as an independent clinical academic and latterly, as a GSK employee.

Sam Hariry

Sam Hariry

Head of Clinical Strategy - Translational Medicine, Novartis

Read more

Sam is the Head for Clinical Trial Strategy across Translational Medicine in the Novartis Institutes for Biomedical Research, and prior to this was responsible for clinical studies focused on the Musculoskeletal Diseases area. The Translational Medicine group is responsible for studies from first into human, PK/PD studies and patient based Proof-of-Concept studies in various diseases, including those that are rare/orphan and with unmet medical need. The trials led by this group are often the first studies in specific patient populations, and Sam has been involved for over 10 years in the evolution of clinical trial methodology and patient engagement in this area.

Christopher Hart

Christopher Hart

Director, Informatics & Information Science, AstraZeneca

Read more

As Director of Informatics and Information Science, Christopher Hart is responsible for the clinical intelligence strategy supporting drug development programs. He represents AstraZeneca in a number of external collaborations including the Transcelerate Placebo and Standard of Care data sharing project.

Chris has interests in translational informatics, clinical information access, trial design including the use of social media mining, and knowledge management. He is an advocate for information access and the application of technology for patient engagement and decision making support in drug development.

He joined AstraZeneca in 1998, he has had a number of senior roles ranging from supporting several Marketing Authorization Applications to early clinical development in oncology before his current position.

Adama Ibrahim

Adama Ibrahim

Senior Clinical Operations Lead, Biogen

Read more

An innovation award winning operational strategy expert and patient engagement thought leader with over 17 years in the NHS on commission by the DOH and in Industry (Hoffman La-Roche, Amgen, ALMAC, ICON and Biogen). Currently part of the DIA Patient Engagement Voluntary Community Leadership team.

Experience across various therapeutic areas and phases of trials in drug development include creation and execution of successful strategies for research protocols and CRO oversight, expertise in technologies such as eCOA and IVRS, creation of optimal drug packaging and administration concepts, mapping the patient journey, planning and executing effective global site and patient engagement campaigns using direct to patient methods, leading and coaching remote and complex global teams.

Notable Achievements include:

  • MBA Dissertation titled Implementing Patient Engagement at a Biotechnology Company – Understanding Internal Stakeholder behaviours
  • Innovation Award Winner on Clinical Endpoints
  • Implemented Lay Language Summary and End of Study Patient Surveys
  • Performed visits to sites in the UK, US, Spain, Czech Republic, Poland and Serbia to gain insights.
  • Women Innovation Network UK Co-Lead (2016 Honorary Mention for Diversity and Inclusion Awards)
  • Setting up Mentoring Programs and Leadership workshops
  • Trustee for a Youth Charity in London

I enjoy the outdoors, travelling and spending time with my daughter.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription


Ali Abbara

Ali Abbara

Academic Clinical Lecturer, Imperial College London

Read more

Dr Abbara trained in medicine at St Bartholomew's and the Royal London Hospital, before specialising in Endocrinology in London. His research interests centre around reproductive endocrinology and during his PhD at Imperial College London, he led on phase 2 trials evaluating the novel reproductive hormone kisspeptin during IVF treatment. Dr Abbara recognises the key importance of patient and public involvement in enhancing the design of research trials, to ensure that trials are acceptable to patients and that outcomes which are important to patients are studied.

Valerie Ansell

Valerie Ansell

Research Sister, UHCW NHS Trust

Read more

‘Valerie Ansell qualified in the early 1980s undertaking a varied and challenging career in Renal Dialysis, Acute Medicine and Critical Care before joining the Research Department in 2008. As a Research Sister her role is to facilitate and support research within Cardiology on industry, academic and in-house studies. She is passionate about patient experience, participation choice and autonomy and with the support of a great team strives to make the patient journey in research easier thereby guaranteeing a retention rate of greater than 95%. A finalist in the Pharma Times NHS Clinical site of the year in 2015 she has also recently graduated with a first class BA (Hons) degree in Early Childhood Development from Warwick University.’

Lars Jöres

Lars Jöres

Clinical Lead CNS Europe, UCB

Read more

Lars Joeres studied Biology at the University in Düsseldorf, Germany and obtained his PhD in molecular biology and genetic regulation and holds an MBA in health care management from the European Business School with a thesis on clinical outcomes and their role in health technology assessments. He is working since 2002 in pharmaceutical industry. He joined UCB in 2005 and had since then various positions in Medical Affairs and Clinical Development. Since 2013 he is working as Clinical Lead for CNS Medical Affairs Europe and is responsible for clinical late phase activities, namely observational research, investigator initiated studies and post approval research.

Emma Sutcliffe

Emma Sutcliffe

Consultant Director, Patient Engagement, Grünenthal

Read more

Emma has been a leader, lobbyist and innovator in healthcare and proponent of the value insights gained from socialized health and patient centricity for 20 years. A medical biochemist who is completing phd research about the impact of social media on medicine, Emma helps the pharma industry upskill and adapt to the era of participatory medicine where everyone is a consumer and a contributor. When she isn't writing articles, chairing events or educating industry, Emma is writing poetry - or failing to parent 2 children, a large dog and an irascible cat.

Ramona Kanters

Ramona Kanters

Patient, The Scleroderma Foundation

Read more

Ramona Kanters is a 39 year old (mother of two) who was diagnosed with Systematic Sclerosis at the age of 32. Systematic Sclerosis is a rare autoimmune decease that occurs in one out of 10.000 people. It involves the thickening and scarring of the skin, muscles, joints and organs.

After a year of extensive chemotherapy and a stem cell transplantation (that saved her life) she decided to devote herself to the support of fellow patients and their partners. To this end, she established a foundation to enhance the awareness of this rare but grave disease. She provides lectures, workshops and counselling sessions at home and abroad, and has recently published a care report in which the system of care surrounding Systemic Sclerosis is analysed, which has been internationally published.

During her activities Ramona has found that it is of crucial importance to involve patients in their own care. She advocates that when patients, physicians and pharmaceutical companies start to work together, care can be greatly optimized. Ramona: ‘Give patients a voice, let doctors and those working in pharmaceutics see the person behind the patient and let the patient see the real person behind the physician. This will make an enormous difference in their wellbeing’.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription


Susan Hamer

Susan Hamer

Director of Nursing, Learning and Organisational Development, National Institute for Health Research

Read more

Dr Susan Hamer is CRN Director of Nursing, Learning and Organisational Development.

Susan is passionate about purposeful change and in particular the development of the healthcare workforce. As lead nurse Susan works with colleagues to ensure that the clinical leadership culture is vibrant and integrated across the large network.

As a committed adult educationalist Susan understands that a positive work environment is key to high performance and leads a team to develop timely, high quality learning and development opportunities using a wide range of approaches. A previous role as national leader in the Department of Health Informatics Directorate persuaded Susan about the possibilities for technology to enhance practice and to support innovation in the development of patient led services. She sees the development of accessible information as crucial to this.

Susan is a regular writer and is the author of “Achieving Evidence-Based Practice” and “Leadership and Management: A Three-Dimensional Approach”. Her clinical background is predominately in the community and she has worked consistently in the fields of leadership and practice development. She has a doctorate in adult education and is a Fellow of the Queens Nursing Institute. In 2012 Susan received the EHI CCIO award for Clinical IT leadership and in 2013 Susan was named one of the Health Service Journal’s Inspirational Women.

Diane Driver

Diane Driver

Head Outsourcing Contracts Strategic Partnerships, UCB

Read more

Diane started her career as a pharmacologist at Smith Kline & French, before switching to Clinical Development in a CRO in 1988. She then spent 12 years taking roles of increasing responsibility and geographical scope, before moving to Pharma in 2000. During her time at UCB she has led global clinical development programs, set up and managed a global in-house monitoring team, as well as spending 3 years outside clinical operations in the strategic role of Global Project Leader where she led global cross functional teams to develop new drug candidates from research through to proof of concept in the clinic. In 2014 she returned to Clinical Operations to head up UCB’s Outsourcing Contracts & Strategic Partnering department, where she is responsible for developing and implementing the global clinical outsourcing strategy and the management /oversight of UCB’s Strategic Partnering relationships. In addition, Diane also represents UCB on the Oversight Committee of TransCelerate.

Richard Stephens

Richard Stephens

Chair, NCRI Consumer Forum

Read more

Richard Stephens is a survivor of two cancers and a heart emergency, and has multiple morbidities and late effects. He has participated in four interventional clinical trials and eight other studies.

He Chairs the NCRI’s Consumer Forum and sits on strategic groups for NIHR, NCRAS, MRC CTU, Genomics England, Cancer Research UK, ABPI and others.

Richard was the patient representative on the Independent Cancer Taskforce that produced the (English) National Cancer Strategy, Achieving World Class Cancer Outcomes, and is a founder member of the AllTrials and useMYdata movements. He is joint Editor-in-Chief of BMC’s Journal of Research Involvement and Engagement.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription


Cathy Emmas

Cathy Emmas

Patient Centricity Partnership Director, AstraZeneca

Read more

Cathy is the Partnership Director in AstraZeneca’s global Patient Centricity team where she leads a 5 year strategic collaboration with the PatientsLikeMe online health network. This alliance was established to accelerate our ability to generate the right patient insight that enables informed decision making within our R&D programs and shape healthcare delivery. In the first two years the collaboration has linked the experiences of over 70,000 patients into our lifecycle teams and patient preferences have helped shape 12 clinical studies across 7 diseases.

Prior to joining Astra in 1993 she completed a PhD at the Imperial Cancer Research Fund and was a postdoctoral researcher at the Royal Postgraduate Medical School. Within Astra she held roles in Clinical Research, Planning and as a Scientific Advisor. She moved to the newly formed Outcomes Research group and established a Real World Evidence team which used routinely collected health data to generate new evidence to support HTA submissions, and medicines at a local and global level. She was a member of the external reference group of the UK Research Capability Programme which lead to the creation of CPRD which links together healthcare data from across the NHS for research purposes.

Jasmine Smith

Jasmine Smith

Trustee, Epilepsy Society

Read more

Jasmine Smith, was 17 years-old when she was diagnosed with a brain tumour which triggered epileptic seizures.  She had hoped to become a ballet dancer but was asked to leave the university where she was studying dancing.  The same happened with several jobs, including cleaning, waitressing and working in a shop. Jasmine, now 25, is seizure free, and as a result of her experiences now works within cardiothoracic critical care at Harefield Hospital, with an interest in epilepsy. She is also an epilepsy ambassador working with Epilepsy Society since 2011; and started working with UCB in 2012, beginning as a patient ambassador and speaking with their medical teams and giving a patient insight into living with epilepsy. For the past 6 months she has been working with the UCB European research team as a patient consultant. 

Danielle Gerlag

Daniëlle Gerlag

Patient Engagement Lead, GSK

Read more

Daniëlle Gerlag, MD PhD, came from an academic background being an associate professor and consultant internist and rheumatologist at the Division of Clinical Immunology and Rheumatology EULAR & FOCIS Centre of Excellence Academic Medical Centre/University of Amsterdam in The Netherlands, where she headed up the clinical trial team performing early phase experimental medicine studies in inflammatory joint diseases for about 10 years. She joined GSK as head of the Clinical Unit in Cambridge in 2013 and transferred to her current role in January 2017. In this role, as a member of the Patient in Partnership team of GSK, she works on the development and implementation of a strategy to collaborate with patients during all phases of medicine development.

tanja_keiper

Tanja Keiper

Director, Biopharma, GCO External Innovation, Merck

Read more

Tanja Keiper, molecular biologist by training holds a doctoral thesis in internal medicine and has been working within Clinical Research & Development in various positions since 2005. She joined Merck KGaA in 2007 and is since 2014 working as member of Global Clinical Operations External Innovation, focusing on patient centricity and innovation in clinical development.

Isabela Niculae

Isabela Niculae

Associate Director, Feasibility, Enrollment, Retention, Optimization, Biogen

Read more

Currently, Isabela Niculae is the Associate Director Pt Feasibility, Enrollment, and Retention Optimization at Biogen responsible for establishing global and corporate strategies to help Biogen be the partner of choice for clinical trial patients.

Isabela has also has held positions as Clinical Program Leader working across all clinical program phases from preclinical through commercialization and life-cycle management.

Isabela earned a Bachelor of Arts in Psychology and Cognitive Science from the University of California at San Diego and a Master’s in Public Health from San Diego State University. She is also currently co-chair of the UK Women’s Innovation Network at Biogen.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription


Thomas Klein

Thomas Klein

Founder and CEO, Be The Partner

Read more

Thomas Klein has more than 20 years of professional experience as an entrepreneur with a proven track record in biotechnology and IT. Before establishing Be the Partner, he founded the biopharmaceutical company NOXXON Pharma AG. In addition, he was founder of the web based precision medicine platform PIRCHE AG and co-founder of the software company ARCWAY AG. Since more than 10 years, Thomas is the legal representative for all clinical trials in Europe of a leading provider of stem cell therapies.

Peter Coë

Peter Coë

Managing Director, Tudor Reilly Health

Read more

Peter has been working with drug developers for over 15 years to promote research, accelerate patient recruitment and bring the patient voice into clinical trials; leading complex programmes in multiple countries and languages, with a focus on digital and online tactics.

Previously, Peter was a lead anchor for BBC TV News and, before that, a business correspondent for the BBC, ITV and Sky News in the UK. He began his career with a journalism scholarship in Washington DC, joining the news agency UPI in the early 1980s; when the worldwide web was still a pipe dream.

Jan Liska

Jan Liska

Global Head Patient Business Strategy | Chief Medical Office, Sanofi

Read more

Jan leads patient value evidence inclusion efforts into direct-to-patient Sanofi’s unbranded and branded activities, optimizing their customer value proposition, positive impact on patient health outcomes and quality of life. Previously, he has served as Global Patient Strategy Lead for Praluent® therapy, delivering projects supporting patients’ disease awareness, medication acceptance and adherence.

Jan joined Sanofi in 2011 as Global Director in Consumer Healthcare team, bringing more than 10 years of experience from hi-level global and regional roles at L’Oréal and Shiseido. Jan holds a M.Sc. European Masters in Management and Diplom Kaufmann degrees from ESCP Europe business school – Paris | Oxford | Berlin.

Dikerik Boot

Diderik Boot

Director – Clinical Program Leader, Janssen

Read more

Diderik Boot is trained as a clinical pharmacologist with over 14 years of experience in clinical drug development having worked for both CRO’s and the pharmaceutical industry. He worked on clinical trials from Phase I up to IV, being involved in their design, performance and reporting. He is currently global clinical program director at Janssen Pharmaceuticals overseeing the clinical operational activities of early development and clinical pharmacology studies within the neuroscience therapeutic field. He has published 19 articles in peer reviewed journals, mostly concerning clinical drug development.

Inês Alves

Inês Alves

Founding Board Member, EUPATI Portugal

Read more

Mother of two children, one has a rare bone disease, athlete; veterinary doctor by training; working full-time in patient advocacy since 2015; Patient Representative in BOND-Rare Bone Diseases group in the European Reference Networks; EUPATI fellow, national ambassador and founding member of EUPATI Portugal; Scientific advisor of ALPE foundation; President of the board of ANDO; Task force member of PFMD-Patient Focused Medicines Development; Invited expert on Health Literacy and Clinical trials for the National School of Public Health, Lisbon University; writer of “Beyond Achondroplasia”, a scientific informative blog on achondroplasia.

Malini Raj

Malini Raj

Chair, Australian Pituitary Foundation;
Treasurer and Board Member, World Alliance of Pituitary Organisations (WAPO)

Read more

Malini is the Chairman and Non-Executive Director of the Australian Pituitary Foundation - not-for-profit organisatIon whose mission is to support and educate people impacted by pituitary conditions by creating awareness and providing information to the general and medical communities, acting as a collective voice for pituitary patients and their families. Malini is also Treasurer and Non-Executive Director of the World Alliance of Pituitary Organisations – created in order to unite the international pituitary patient community.

Aside from these voluntary roles, Malini has worked for over 15 years in the financial services industry, in several domestic and international institutions in areas of Accounting, Property, Financial Markets, Project Management, HR, Business Strategy, Small Business & Change Management in Retail & Institutional Banking. She is now Head of Strategy for Multicultural Community Banking at a major financial institution in Sydney Australia.

Malini is also a pituitary patient – diagnosed with Cushings disease in 2013 and is passionate about driving strategies and initiatives to provide support to those who have experienced pituitary conditions and their families and promoting advocacy and awareness amongst the medical community and the public with a view of improving their quality of life.

jennifer_o_callaghan

Jennifer O’Callaghan

Clinical Data Sharing Manager, Wellcome Trust

Read more

Jennifer O’Callaghan works as the Clinical Data Sharing Manager for Wellcome Trust. In this role Jennifer leads on Wellcome’s clinical trial data sharing activities, managing a number of data sharing initiatives including running the independent review panel secretariat for ClinicalStudyDataRequest.com, an initiative involving trial data from 13 pharmaceutical companies including Astellas, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eisai, GSK, Lilly, Novartis, Roche, Sanofi, Takeda, UCB and ViiV Healthcare. Jennifer also manages the Ebola Virus Clinical Trials Data Access Committee in partnership with the Infectious Disease Data Observatory at Oxford University. Jennifer also contributes to Wellcome’s data sharing policy and advocacy work and is an active member of the European Collaborative Research Infrastructure Network working group on data sharing and the Harvard Multi-Regional Clinical Trials Center’s clinical trials data sharing working groups.

Martin Collyer

Martin Collyer

Chief Operations Officer, Bioclinica Patient Recruitment & Retention Division

Read more

Martin Collyer is a senior healthcare and life sciences executive with more than 20 years of experience and a strong operations and finance background. As COO of Bioclinica’s Patient Recruitment & Retention division, Martin enables organizations to expedite the enrollment of patients into clinical trials utilizing therapeutically-aligned global patient engagement platforms and digital methodologies. Prior to joining Bioclinica in 2016 he was with Hitachi for four years solving big data challenges.

Peter Shone

Peter Shone

Corporate VP, Engineering, PAREXEL International

Read more

Peter leads Engineering at PAREXEL Informatics with teams based worldwide. His role is to drive technology innovation in analytics, business intelligence, big data management and mobile technologies in addition to ensuring the robust and reliable delivery of quality products across Patient Sensors, Medical Imaging, EDC, RTSM, CTMS and RIM solution areas.

Robin Marcus

Robin Marcus

Senior Vice President, Business Development and Strategic Initiatives, GlobalCare Clinical Trials

Read more

Robin Marcus is a Sr.VP with GlobalCare Clinical Trials. Over the past 25 years Robin has become known as an innovative healthcare executive focused on operationalizing new products and services. Her talents have been leveraged with companies of all sizes including Caremark, Mediware, Home Healthcare Laboratory of America, and Integrity Health Care. She began her professional career as a an Oncology and Bone Marrow Transplant Nurse in San Francisco after receiving her BA from University of California San Diego and her BSN from The University of San Francisco.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription